BackgroundIncreasing the establishment of integrated management systems (IMSs) is done with the purpose of leaving traditional management methods and replacing them with modern management methods. Thus, the present study sought to analyze the events and investigate the impact of IMS on health and safety performance indices in an Iranian combined cycle power plants.MethodsThis case study was conducted in 2012 in all units of the Yazd Combined Cycle Power Plant on accident victims before and after the implementation of IMS. For data analysis and prediction of indices after the implementation of IMS, descriptive statistics and Kolmogorov–Smirnov test, Chi-square, linear regression, and Cubic tests were conducted using SPSS software.ResultsThe number of people employed in the power plant in an 8-year period (2004–2011) was 1,189, and 287 cases of work-related accidents were recorded. The highest accident frequency rate and accident severity rate were in 2004 (32.65) and 2008 (209), respectively. Safe T-score reached to below −3 during 2010–2011. In addition, given the regression results, the relation between all predictor variables with outcomes was significant (p < 0.05), except for the variable X1 belonging to the accident severity rate index.ConclusionThe implementation of safety programs especially that of IMS and its annual audits has had a significant impact on reducing accident indices and improving safety within the study period. Accordingly, health and safety management systems are appropriate tools for reducing accident rate, and the use of regression models and accident indices is also a suitable way for monitoring safety performance.
Purpose
To determine the relationship of illnesses and medical drug consumption with the occurrence of traffic accidents among truck and bus drivers.
Methods
This is a cross-sectional study on truck and bus drivers in Tehran, Iran. The criteria for participating in this study were: married males over 30 years old, driving license in grade one, five years of job experience, mental health and non-addiction license. The criterion for not participating in this study was the lack of cooperation in responding to the questions. Six months was spent to collect the latest five years data of driving accidents from 2011 to 2016. A total of 323 truck and bus drivers in Tehran city and the suburbs, Iran were chosen. Among them, 112 were responsible for accidents (accident group) while 211 were not responsible for any accidents or involved in an accident in the last five years (non-accident group). A specially designed questionnaire was used to investigate the demographic information, medical drug consumption, medical backgrounds and history of accidents.
Results
The results revealed that compared with healthy subjects, the occurrence of accidents among people with diabetes (
OR
= 2.3,
p
= 0.001) and vision weakness (
OR
= 1.7,
p
= 0.020) was significantly higher, while that among people with cardiac (
OR
= 0.5,
p
= 0.002) and hypertension (
OR
= 0.9,
p
= 0.048) problems was remarkably lower. Moreover, consumption of Gemfibrozil (
OR
= 1.8,
p
= 0.010) and Glibenclamide (
OR
= 2.2,
p
= 0.002) drugs resulted in significantly higher incidence of accidents than those without.
Conclusion
Frequencies of illnesses like cardiovascular and hypertension were not higher in accident drivers than in non-accident drivers; but diabetes, vision weakness and consumption of Gemfibrozil and Glibenclamide lead to more traffic accidents.
The results of the study can be used to address ergonomic risk factors and reduce their associated disorders. The findings of the study can be used in training programs to educate drivers how to decrease the risk associated with work-related MSDs by adopting appropriate behavior strategies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.